Bristol Myers Squibb logo

Patient Strategy Manager

Bristol Myers Squibb

Guaynabo, PROnsitePosted 3 days ago$92,670 - $112,291
Full TimeSenior LevelCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

The Patient Strategy Manager is a member of the Brand Team who translates brand strategy into patient-facing execution across the Hematology, Oncology and Cell Therapy portfolio. The role owns patient journey insight, direct-to-consumer (DTC) omnichannel content, the tracking and local adaptation of US patient materials, and professional society and congress engagement, and supports Corporate Affairs-led disease awareness campaigns.

Job description

Position Summary

The Patient Strategy Manager is a member of the Brand Team who translates brand strategy into patient-facing execution across the Hematology, Oncology and Cell Therapy portfolio. The role owns patient journey insight, direct-to-consumer (DTC) omnichannel content, the tracking and local adaptation of US patient materials, and professional society and congress engagement, and supports Corporate Affairs-led disease awareness campaigns.

Key Responsibilities

Patient Strategy Execution: Co-creates the annual patient plan with Brand Leads and the Corporate Affairs Lead, escalating competing priorities to the Business Unit Director. Translates brand strategy into patient-facing execution plans. Accountable for the quality, timeliness and compliance of patient-facing tactics, and for defining and reporting their success metrics. Manages assigned budget and agency/vendor support, and uses field and market insight to continuously improve patient engagement.

Patient Journey and Insight: Owns the patient journey for each brand, from diagnosis through treatment initiation and adherence, identifying friction points that limit outcomes. Maintains the cell therapy referral-to-treatment pathway, including referral, apheresis, bridging therapy, caregiver requirements and treating center logistics. Integrates market research, BI&A analytics, secondary data, and field and Corporate Affairs insight into patient segmentation and actionable recommendations.

Omnichannel and DTC Content: Owns end-to-end DTC patient content, from omnichannel strategy and creation through deployment, including Spanish-language development and cultural adaptation. Partners with the Omnichannel COE and BI&A to measure and optimize DTC channel performance.

US Materials Tracking, Adaptation and Local Approval: Monitors all US disease awareness and product-related patient materials across the portfolio, maintaining a central tracker of new releases, updates, label changes and withdrawals. Assesses each US material for relevance to Puerto Rico patients and recommends whether to use as-is, adapt, adjust or not deploy locally. Leads the adaptation process: Spanish translation and linguistic quality review, cultural and health-literacy adjustments, and alignment with local labeling, access and patient support programs. Guides each material through local Medical, Legal and Regulatory review and approval. Maintains version control, approval status and expiration/re-certification dates.

Corporate Affairs Support: Provides disease-state content, patient journey insight and burden-of-illness material for Corporate Affairs-led disease awareness campaigns and corporate initiatives. Develops and adapts Spanish-language disease awareness materials on request.

Professional Society and Congress Engagement: Owns relationships with hematology and oncology professional societies in Puerto Rico against defined annual objectives. Leads the end-to-end congress and events process, from planning and cross-functional coordination through compliant execution and post-event assessment.

Qualifications & Experience

  • Bachelor's degree in business administration, science, marketing or related field
  • 5+ years' pharmaceutical industry experience, including 3+ years in oncology, hematology or cell therapy
  • Fully bilingual in Spanish and English, able to develop, translate and adapt content in both languages
  • Experience developing patient-facing and disease awareness content across digital and omnichannel channels, including MLR review and local adaptation of US or global materials
  • Strong knowledge of patient journeys and ability to turn BI&A analytics and segmentation into action
  • Proven success in a matrix organization, building relationships across Corporate Affairs, Medical, Regulatory, Access, PASS and Sales

Requirements

  • Bachelor's degree in business administration, science, marketing or related field
  • 5+ years' pharmaceutical industry experience
  • 3+ years in oncology, hematology or cell therapy
  • Fully bilingual in Spanish and English
  • Experience developing patient-facing and disease awareness content across digital and omnichannel channels
  • Experience with MLR review and local adaptation of US or global materials
  • Strong knowledge of patient journeys
  • Ability to turn BI&A analytics and segmentation into action
  • Proven success in a matrix organization

Benefits

  • Wellbeing Support
  • Retirement Benefits
  • Financial Protection Benefits
  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Flexible Time Off
  • 11 Paid Company Holidays
  • Paid Vacation
  • Paid Sick Leave
  • Paid Volunteer Days
  • Summer Hours Flexibility
  • Annual Global Shutdown

Company overview

Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.